EU Green Pass: Serum Institute applies to EU agencies for Covishield approval
The Serum Institute of India (SII) has applied to the European Medicines Agency (EMA)-the regulatory body of Europe for the inclusion of SII manufactured Covishield in the list of approved vaccines for the EU 'Green Pass.' The pass is required for easy travel to and within the EU and will be launched from July 1.
READ MORE:
Other Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
USV | Take heart: Steering preventive strategies for charting a journey towards cardiac wellness
Beat Diabetes With Lifestyle Modification
Serum to double investment in Biocon's unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw
India is stepping up genome sequencing of COVID 19 positive samples amid growing outbreaks in China, Japan and South Korea
